RxSight, Inc.
RXST
$25.77
$0.552.18%
Weiss Ratings | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.33 | |||
Price History | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -3.08% | |||
30-Day Total Return | -21.58% | |||
60-Day Total Return | -30.91% | |||
90-Day Total Return | -49.13% | |||
Year to Date Total Return | -25.41% | |||
1-Year Total Return | -44.22% | |||
2-Year Total Return | 69.76% | |||
3-Year Total Return | 124.09% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -62.10% | |||
52-Week Low % Change | 2.35% | |||
Price | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $66.54 | |||
52-Week Low Price | $24.64 | |||
52-Week Low Price (Date) | Mar 10, 2025 | |||
52-Week High Price (Date) | May 07, 2024 | |||
Valuation | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 1.02B | |||
Enterprise Value | 796.24M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.71 | |||
Earnings Per Share Growth | -49.93% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 7.27 | |||
Price/Book (Q) | 3.63 | |||
Enterprise Value/Revenue (TTM) | 5.69 | |||
Price | $25.77 | |||
Enterprise Value/EBITDA (TTM) | -23.92 | |||
Enterprise Value/EBIT | -21.60 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 40.36M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 949 521 7830 | |||
Address | 100 Columbia Aliso Viejo, CA 92656 | |||
Website | www.rxsight.com | |||
Country | United States | |||
Year Founded | 1997 | |||
Profitability | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -26.34% | |||
Profit Margin | -19.62% | |||
Management Effectiveness | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -9.19% | |||
Return on Equity | -- | |||
Income Statement | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 139.93M | |||
Total Revenue (TTM) | 139.93M | |||
Revenue Per Share | $3.47 | |||
Gross Profit (TTM) | 98.94M | |||
EBITDA (TTM) | -33.28M | |||
EBIT (TTM) | -36.86M | |||
Net Income (TTM) | -27.46M | |||
Net Income Avl. to Common (TTM) | -27.46M | |||
Total Revenue Growth (Q YOY) | 40.71% | |||
Earnings Growth (Q YOY) | 35.29% | |||
EPS Diluted (TTM) | -0.71 | |||
EPS Diluted Growth (Q YOY) | 42.36% | |||
Balance Sheet | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 237.22M | |||
Cash Per Share (Q) | $5.88 | |||
Total Current Assets (Q) | 293.82M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 281.24M | |||
Current Ratio (Q) | 11.355 | |||
Book Value Per Share (Q) | $6.96 | |||
Total Assets (Q) | 318.56M | |||
Total Current Liabilities (Q) | 25.88M | |||
Total Debt (Q) | 12.30M | |||
Total Liabilities (Q) | 37.33M | |||
Total Common Equity (Q) | 281.24M | |||
Cash Flow | RXST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -99.31M | |||
Cash from Financing (TTM) | 123.32M | |||
Net Change in Cash (TTM) | 7.05M | |||
Levered Free Cash Flow (TTM) | -9.81M | |||
Cash from Operations (TTM) | -16.95M | |||